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Introduction: Bipolar disorder (BD) is a debilitating mental illness proven to be very 
difficult to treat. By studying the molecular mechanisms that underlie BD, we can learn how to 
improve treatments. The CLOCK protein is a key transcription factor involved in the persistence 
of circadian rhythms. Studies have found that manipulations of the Clock gene are sufficient to 
produce manic-like behavior in mice. The Clock 3111T/C single-nucleotide polymorphism 
(SNP) is a variation of the human Clock gene that is associated with increased frequency of 
mania in BD patients. In this study, we sought to examine the functional implications of the 
Clock 3111T/C SNP on Clock and Per2 expression over 24 hours. 
Materials and Methods: Plasmid construction: The human Clock gene was cloned and 
site-directed mutagenesis was performed to produce the 3111T and 3111C versions of the gene. 
An Npas2 shRNA was also constructed in order to knockdown Npas2 expression, which has 
been shown to be significantly upregulated in Clock KO MEFs. MEFs: Mouse embryonic 
fibroblasts (MEFs) were collected from Clock Knockout (KO) mice. Clock KO MEFs were used 
to avoid confounds of endogenous Clock expression. Transfections: MEFs were transfected with 
either the Clock T or C constructs, in addition with an Npas2 shRNA. Quantitative PCR: RNA 
from transfected MEFs was isolated, and then reverse-transcribed to cDNA. Quantitative 
polymerase chain reaction (qPCR) was performed over a 24 hour period. 
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 Results: Quantitative PCR revealed significantly increased levels of Clock and Per2 
mRNA over a 24-hour time course in MEFs expressing the 3111C SNP, as compared with 
3111T. 
 Conclusions: The CLOCK protein controls expression of genes beyond the circadian 
clock. These include dopamine regulators, which are known to be involved in decreased 
depression-like behaviors and increased impulsivity/drug intake. From this, it is clear that altered 
Clock expression may have tremendous implications for a variety of diseases, including BD. 
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1. INTRODUCTION 
Bipolar Disorder (BD) is a severe and chronic psychiatric disease that afflicts approximately 1-
3% of the United States population (Kupfer et al., 2011). BD incurs substantial societal burdens 
including a devastating global cost of illness primarily due to patients’ lower levels of 
functioning, greater severities of disability, longer duration of illness, and ultimately greater 
losses in productivity when compared to other mood disorders (Budde et al., 2003; Pini et al., 
2005). BD therapies currently in use include mood stabilizers such as lithium and valproate, 
however these are effective for only a portion of patients (for review, see McClung, 2007). The 
underlying cause of BD is unknown, though there is a growing body of evidence linking 
disruptions in circadian rhythms with the disease. 
Disruption of sleep and circadian rhythms are common to many psychiatric disorders, 
and severe circadian rhythm disruptions in a variety of measures are prominent symptoms in 
patients with BD. It has been shown that in individuals with BD, mood episodes are affected by 
light and also follow seasonal patterns (for review, see McClung, 2007). In addition to 
fluctuations in mood, BD patients typically exhibit irregularities in important physiological 
processes that are largely regulated by the body’s circadian rhythms (such as sleep, diurnal 
activity, body temperature, and blood pressure cycles). Mood stabilizers such as lithium are 
known to restore some of these disrupted rhythms in BD patients by producing a strong phase-
delay in rhythms and increasing rhythm amplitude, which may be very important for their 
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therapeutic effects (Atkinson et al.,1975; Johnsson et al., 1983; Klemfuss, 1992; Kripke et al., 
1978; Dokucu et al., 2005; Gould and Manji, 2005; Iwahana et al., 2004). Here, we investigate 
the role of a single-nucleotide polymorphism in the circadian gene, Clock, that has been 
associated with BD (Benedetti et al., 2003). By studying molecular mechanisms that may 
underlie BD symptoms, we can gain a better understanding of its causes and how to most 
effectively treat patients with this crippling disease. 
Circadian rhythms are regulated by a molecular clock, which consists of several ‘clock’ 
genes (i.e. Clock, Npas2, Bmal1, Per1, and Per2) that are expressed throughout the body. These 
elements interact with each other through a series of transcriptional and translational feedback 
loops that are regulated over a 24-hour period in the absence of environmental input (Takahashi 
et al., 2008). Within the suprachiasmatic nucleus (SCN) and other regions, circadian rhythms are 
controlled by the molecular clockwork, which is comprised of a series of autoregulatory 
transcriptional-translational feedback loops.  The transcription factors CLOCK (or NPAS2) and 
BMAL1 heterodimerize and activate transcription of target genes, including the Period (Per) and 
Cryptochrome (Cry) genes, which act to inhibit the activity of the CLOCK/BMAL1 complex. 
Several pre-clinical studies have identified an important role for circadian genes in mood-related 
behaviors (for review, see McClung, 2011). Recent human genetic studies have linked elements 
of the molecular clockwork to BD. Polymorphisms in Clock and other circadian genes have been 
found to be associated with various aspects of bipolar disorder (Lamont et al., 2010; Soria et al., 
2010; Mansour et al., 2006; Mansour et al., 2009; Kripke et al., 2009; Sjoholm et al., 2009; 
Lamont et al., 2007). In addition, rhythm disruptions and sleep disturbances are common in BD 
and often precipitate manic or depressive episodes (Harvey et al., 2011).  
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The importance of circadian genes in BD has been suggested by several human genetic 
studies that have identified significant associations between mutations or polymorphisms of 
circadian genes and BD. The Per genes, which act as key repressors of the circadian 
transcriptional-translational feedback loop in humans, have been found to associate with mood 
disorders and their age of onset (Nievergelt et al., 2006; Benedetti et al., 2008). Recent genome-
wide association studies (GWAS) have also implicated circadian modulators such as ARNTL and 
DEC1 as significantly associated with BD (McCarthy et al., 2012). These results are particularly 
important given data from family and twin studies that have established BD’s genetic heritability 
as up to 85%, suggesting a strong genetic component of this disease (McGuffin et al., 2003). 
Interestingly, the Clock 3111T/C single-nucleotide polymorphism (SNP) is a genetic variant of 
the human Clock gene that has been associated with bipolar mania in BD patients. Specifically, 
this TàC polymorphism (rs1801260) associates with increased actimetric and sleep disturbances 
and incidences of manic episodes in bipolar patients (Benedetti et al., 2003; Benedetti et al., 
2007; Seretti et al., 2005). The prevalence of the 3111C has been reported to be between 19-21% 
in American populations (Desan et al., 2000). BD patients carrying the 3111C allele experience 
higher rates of insomnia and sleep disturbances, and differences between the 3111C and 3111T 
allele carriers were attenuated with ongoing chronic lithium treatment (Seretti et al., 2005). No 
research group, however, has yet sought to determine the molecular mechanism through which 
this SNP can affect individuals with BD. The 3111T/C SNP is located within the Clock gene’s 3’ 
untranslated region (3’UTR). The 3’UTR is a region that has been shown to be very important 
for mRNA stability and modifications to this region can lead to either increased stability or 
degradation of gene products (Hentze et al., 1996; Zaidi et al., 1994).  
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Moreover, preclinical studies have shown that manipulations of the circadian gene, 
Clock, are sufficient to produce a behavioral phenotype sharing several features with bipolar 
mania. Mice with a dominant-negative Clock gene mutation exhibit a manic-like phenotype, 
including hyperactivity, reduced anxiety and depression-like behaviors, and increased drug and 
alcohol intake (McClung et al., 2005; Roybal et al., 2007; Ozburn et al., 2012; Ozburn et al., 
2013). Similar to human BD patients, these mutant mice are responsive to chronic lithium, as 
well as valproate, treatment (Coque et al., 2011; Dzirasa et al., 2010; Logan et al., in prep).  
Together, these results have led us to hypothesize that the 3111C SNP in the Clock gene 
decreases Clock mRNA and/or protein levels, and that this could be a possible mechanism 
through which this polymorphism can affect mood in individuals with BD. In this study, we 
investigated the effects of the human 3111T/C SNP on Clock mRNA and protein in a 
mammalian cell line by examining the differences between the 3111T and 3111C variants of 
Clock. The human Clock gene was cloned and transfected into Clock Knockout (KO) mouse 
embryonic fibroblasts (MEFs). Quantitative real-time polymerase chain reaction (RT-PCR) 
studies were completed to quantify mRNA levels, allowing us to measure differences in Clock, 
Per2, and Npas2 mRNA expression and stability between the two variants of the 3111T/C SNP. 
Circadian gene expression assays were performed to understand the effects of the 3111T/C SNP 
on gene expression over a 24-hour time course. Additionally, we performed gel electrophoresis 
and quantitative Western Blotting to measure CLOCK protein levels. Surprisingly, our results 
revealed that 24-hour Clock mRNA levels were significantly increased in the 3111C SNP when 
compared to the 3111T variant. We also found that 24-hour Per2 gene expression was increased 
in cells expressing Clock 3111C, suggesting that the CLOCK protein’s transcriptional activity 
was also increased by the polymorphism. 
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2. MATERIALS AND METHODS 
2.1 PLASMID CONSTRUCTION 
The pBluescript II plasmid containing the full human Clock gene (product i.d. ORK00509, 
Kazusa), was digested with Apa1 and Not1 restriction enzymes. The DNA fragment containing 
the Clock gene was isolated using agarose gel electrophoresis and the QIAQuick gel purification 
kit (catalog no. 28704, QIAGEN). The 5kb Clock containing fragment was ligated into the 
pcDNA3.1(-) plasmid (catalog no. V795-20, Invitrogen) digested with Apa1 and Not1 restriction 
enzyme sites (5’ end and 3’ end, respectively) and treated with Calf Intestinal Phosphatase to 
prevent self-ligation. The ligated plasmids were transformed into One-Shot TOP10 Chemically 
Competent E. Coli cells (catalog no. C4040-10, Invitrogen). We performed site-directed 
mutagenesis of the Clock construct at the site of the 3111T/C SNP using the Quikchange II XL 
Site-Directed Kit (catalog no. 200521, Agilent) to perform a C to T transformation, creating a 
3111T version of the Clock gene 3’UTR (forward primer: 5’-
GAGGTGATCATAGGGGCATAGCCAGTTCTGACAGTG-3’, reverse primer: 5’-
CACTGTCAGAACTGGCTATGCCCCTATGATCACCTC-3’). The full construct was verified 
through a series of restriction enzyme digests and complete sequencing of the Clock gene 
(including cloning junctions) by the University of Pittsburgh Genomics and Proteomics Core 
Laboratories. Isolated and sequence verified clones were grown in E. coli and plasmids were 
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isolated using QIAGEN’s QIAprep Spin Miniprep kit (catalog no. 27104) and endonuclease-free 
Plasmid Maxi Kit (catalog no. 12162). 
2.2 SHRNA CONSTRUCTION 
A small hairpin RNA (shRNA) was constructed against the Npas2 gene by selecting a 24 base 
sequence (5’-GAACACTGGATTCTTCCTGTTAAC -3’) in the 3’-UTR.  For the scrambled 
(Scr) shRNA, a random sequence of 24 bases (5’-CGGAATTTAGTTACGGGGATCCAC-3’) 
that had no sequence similarities with any known genes/mRNA was used (Mukherjee et al., 
2010). An anti-sense sequence of the selected mRNA region followed by a miR23 loop of 10 
nucleotides (CTTCCTGTCA) was added at the 5’end of the above sequences. The miR23 loop 
facilitates the transfer of the hairpin RNA out of the nucleus. These shRNAs were designed as 
synthetic duplexes with overhang ends identical to those created by Sap I and Xba I restriction 
enzyme digestion. The annealed oligonucleotides were cloned into the adeno-associated virus 
(AAV) plasmid expressing enhanced green fluorescent protein (GFP) (catalog no. 240075, 
Agilent Technologies). 
2.3 PREPARATION OF MEFS 
Mouse embryonic fibroblasts (MEFs) were isolated and prepared from Clock Knockout mice at 
13-14 day post-coitum as described in (Jozefczuk et al., 2012). Clock KO MEFs were used to 
avoid confounds of endogenous Clock gene expression when measuring expression levels in 
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MEFs transfected with the 3111T/C constructs. Briefly, uterine horns were dissected, and 
embryos were individually separated. The head and red organs were removed before the embryos 
were finely minced using a sterile razor blade. Minced tissue was treated with 0.05% Trypsin-
EDTA (Gibco, Invitrogen) and DNase I (USB), and incubated for 15 minutes at 37°C. Cells 
were centrifuged at 600 x g for 5 minutes, and supernatant was carefully removed before 
resuspending the MEF cell pellet in a warm solution of media containing high-glucose 
Dulbecco's Modified Eagle Medium (DMEM) with L-glutamine (catalog no. 11965-084, 
GIBCO), supplemented with 10% FBS (catalog no. 16000-044, GIBCO), 100 units/ml penicillin, 
100 units/ml streptomycin, and 1mM sodium pyruvate (catalog no. 11360-070, GIBCO). MEFs 
were stored at -80°C. 
2.4 CELL CULTURE/TRANSFECTIONS 
MEF cells were cultured at 37°C with 5% CO2 in high-glucose DMEM with L-glutamine, 
supplemented with 10% FBS, 100 units/ml penicillin, 100 units/ml streptomycin, and 1mM 
sodium pyruvate. Cells were grown to 80-100% confluence before being split using 0.25% 
Trypsin-EDTA with phenol red (catalog no. 25200-056, GIBCO). MEFs were transfected with 
plasmid construct(s) using Lipofectamine LTX (catalog no. 15338-100, Invitrogen) and Opti-
MEM I Reduced Media Serum (catalog no. 31985-062, Invitrogen) according to the 
manufacturer’s instructions. Following transfections, cells were collected for RNA isolation in 
qPCR or Western Blot studies. 
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2.5 RNA ISOLATION/CDNA SYNTHESIS 
Approximately 1x105 cells were transfected with 2µg of the 3111T or 3111C versions of the 
Clock SNP. 72 hours following transfection with expression constructs, cells were selected using 
100µg/ml Geneticin Selective Antibiotic (catalog no. 10131-035, GIBCO) to generate stable 
lines. After selection, RNA from the MEFs was isolated using TRIzol reagent (catalog no. 
15596-026, Ambion), according to the manufacturer’s instructions. Briefly, cells were treated 
with TRIzol reagent and chloroform, and RNA was isolated with the addition of the carrier 
glycogen, followed by precipitation in isopropanol and centrifugation. 75% ethanol was used to 
wash the RNA pellet, which was re-suspended in nuclease-free H2O. Total RNA (200ng) was 
treated with DNase I (Catalog no. 18068-015, Invitrogen), and then reverse-transcribed to cDNA 
using the SuperScript III First-Strand Synthesis System (catalog no. 18080-051, Invitrogen) 
according to manufacturer’s protocols.  
2.6 REAL-TIME PCR 
Real-time quantitative polymerase chain reaction (RT-PCR) was completed using the 7900HT 
Fast Real-Time PCR System (catalog no. 4329003, Applied Biosystems). cDNA samples were 
prepared with the Power SYBR Green qPCR Master Mix (catalog no. 4367659, Applied 
Biosystems) along with oligo primers for hClock (forward primer: 5’-
ATGGGCCAGGTGGTGACTGCAT-3’, reverse primer: 5’-
TGACCCAGCCACCGCAACAAT-3’), mNpas2 (forward primer 5’-
GACACTGGAGTCCAGACGCAA-3’, reverse primer 5’-
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AATGTATACAGGGTGCGCCAAA-3’), G418-resistance gene present in pcDNA3.1(-) 
(forward primer: 5’-CGCATGATTGAACAAGATGGATTGC-3’, reverse primer: 
5’GTTCATTCAGGGCACCGGACA-3’), mPer2 (forward primer 5′-
GAGTGTGTGCAGCGGCTTAG-3′, reverse primer 5′-GTAGGGTGTCATGCGGAAGG-3′) 
and m18s (forward primer 5’- ACCGCAGCTAGGAATAATGGA-3’; reverse primer 5’-
GCCTCAGTTCCGAAAACCA-3’). PCR reactions were run in duplicate, followed by a 
dissociation reaction, and were subjected to agarose gel electrophoresis to determine specificity 
of the amplified product. Gene expression was quantified using the ∆∆CT (CT=cycle threshold) 
method as described in (Tsankova et al., 2004). Gel electrophoresis of the samples was then 
performed in order to further confirm the correct size of the amplified PCR products. 
 
2.7 CIRCADIAN GENE EXPRESSION ASSAY 
Approximately 1x104 cells were plated in 12-well plates, and were doubly-transfected with 1µg 
each of pcDNA3.1(-) (containing the 3111T, 3111C or no insert), and a plasmid containing an 
Npas2 shRNA with a GFP reporter or a scramble plasmid with a GFP reporter. A caveat of using 
Clock KO MEFs was that previous research has shown that KO of the Clock gene results in 
increased Npas2 expression, possibly as a compensatory mechanism (Ozburn and Falcon, 
submitted). Because, as a CLOCK homolog, NPAS2 also regulates Per2 gene expression, an 
Npas2 shRNA was co-transfected along with either versions of the 3111T/C SNP when 
measuring Per2 circadian gene expression in qPCR studies. 72 hours following transfection, 
MEFs were subjected to serum shock to synchronize individual molecular rhythms as described 
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in (Izumo et al., 2003). Briefly, cells were serum shocked using DMEM supplemented with 50% 
horse serum for 30 minutes. After the serum shock treatment, MEFs were switched to recovery 
media containing high-glucose DMEM with L-glutamine supplemented with 2% B-27 (catalog 
no. 17504-044, GIBCO), 350mg/l sodium bicarbonate, 0.25% penicillin/streptomycin, and 
10mM HEPES (catalog no. 15630-106, GIBCO). Cells were collected every 3 hours for the next 
27 hours (and processed as described in RNA isolation/cDNA synthesis section). Samples were 
then used to measure circadian gene expression (as described in Real-Time PCR section). 
2.8 WESTERN BLOT 
Western Blot assays were run similar to previously published protocols (Falcon et al., 2013). 
However, we were unable to confirm the presence of a CLOCK band using denaturing sample 
lysis and SDS-PAGE protocols. Our lab has had success using the CLOCK H-276 antibody 
(Santa Cruz Biotechnology) for chromatin immunoprecipitation (ChIP) assays (Ozburn and 
Falcon et al., submitted). Since ChIP assays are carried out in non-denaturing conditions, we are 
in the process of carrying out this experiment again using native sample and PAGE conditions. 
72 hours after transfection, cells were trypsinized and resuspended in RIPA buffer with protease 
inhibitors (Roche, San Francisco, CA; Sigma, St. Louis, MO). Samples were sonicated and 
centrifuged at 15,000xg for 15 min, supernatant was subsequently collected and protein 
concentrations were determined using a Bradford assay (Bio-Rad, Hercules, CA). Samples will 
be run on a 10% native gel (acrylamide/bisacrylamide), transferred to a 0.22µm PVDF 
membrane, blocked in LiCor Odyssey blocking buffer, incubated with primary antibodies 
(CLOCK H-276) and then incubated with fluorescent secondary antibodies (LiCor Bioscience). 
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Blots will be visualized and quantified using a LiCor Odyssey fluoresence imaging system. All 
samples will be normalized to Anti-Neomycin Phosphotransferase (Millipore). 
2.9 STATISTICS 
All data is presented as the mean +/- standard error of the mean (s.e.m.). Two-way analysis of 
variance (ANOVA) and Student’s t-tests were performed to determine significant differences 
between experimental groups and time points. Statistical outliers were identified as +/- 2x 
standard deviation of the mean and removed prior to further data analysis. 
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3. RESULTS 
3.1 NPAS2 GENE EXPRESSION IN MEFS AND KNOCK-DOWN 
NPAS2, a homolog of CLOCK, can heterodimerize with BMAL1 and positively regulate the 
transcription of Per and Cry genes. Since it is possible that Npas2 may be upregulated in Clock 
KO MEFs, Npas2 expression in WT and Clock KO MEFs was previously measured using qPCR 
by Edgardo Falcón, a graduate student at UT Southwestern. After normalizing CT values to 
GAPDH, we performed a two-tailed unpaired student’s t-test on our preliminary data which 
revealed a statistically significant difference between mean ∆CT values (n = 2, Figure 1 (left)). 
This data shows a 4.59-cycle increase in Npas2 expression in Clock KO MEFs compared to WT 
MEFs (student’s t-test, p < 0.05). We then designed an shRNA to knockdown expression of 
Npas2. Npas2 shRNA resulted in a decrease in Npas2 expression as compared with scramble 
shRNA, as qPCR studies revealed that Npas2 gene expression was undetected after 40 cycles of 
PCR in cells expressing the Npas2 shRNA. Representative data from ZT21 is shown (Figure 1 
(right), representative data from ZT21).  
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Figure 1: Npas2 expression and Knockdown in Clock KO and wild-type (WT) MEFs. (Left panel) Npas2 
expression is significantly increased in Clock knockout MEFS. * = P < 0.05. (Right panel) Npas2 shRNA results in 
significantly decreased Npas2 expression as compared with Scramble shRNA. 
3.2 CLOCK 3111T/C GENE EXPRESSION 
To better understand the effects of the Clock 3111T/C SNP on mRNA expression and stability, 
we transfected Clock KO MEFs with either version of the SNP and sought to measure 
differences in Clock mRNA levels between cells expressing the 3111C and 3111T alleles. Using 
primers for the human Clock gene, our studies revealed that cells expressing the 3111C allele 
showed a 4.17-fold increase in Clock mRNA levels (student’s t-test, p < 0.05, n = 8 Figure 2). 
 
 
 
 
 
 
 
Mean CT
Undetermined
Undetermined
34.12
37.24Clock 3111T + scramble
Experimental Group
Clock 3111C + Npas2 KD
Clock 3111T + Npas2 KD
Clock 3111C + scramble
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Figure 2: Fold change difference in Clock 
levels in Clock 3111T/C-expressing MEFs. 
Clock 3111C gene expression is significantly 
higher than 3111T expression. * = P < 0.05. 
 
 
 
 
 
3.3 24-HOUR CLOCK 3111T/C AND PER2 GENE EXPRESSION 
To test the functional implications of the Clock 3111T/C SNP on Clock mRNA expression and 
stability over a 24-hour time period, we transfected Clock KO MEFs with either version of the 
SNP and sought to measure differences in Clock mRNA levels between cells expressing the 
3111C and 3111T alleles. Our findings show that MEFs transfected with the 3111C construct 
showed significantly increased levels of Clock mRNA at every time point measured, excluding 
ZT18 (n = 12, Figure 3). Using a 2-way ANOVA, we found a highly significant SNP x time 
interaction; SNP x time [F = (21, 93) = 5.34, P < 0.0001]. The main effect of the SNP was highly 
significant; [F = (3, 93) = 156.45, P < 0.0001], as was the main effect of time; [F= (7, 93) = 
16.68, P < 0.0001]. Bonferroni post-hoc test results (presented in Figure 3) reveal significant 
differences in Clock expression in MEFs co-transfected with 3111T or C SNP constructs (along 
with Npas2 shRNA). We were primarily interested in these group comparisons (due to the 
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upregulation of Npas2 in Clock KO MEFs). There were no significant differences in Clock 
expression seen in cells transfected with or without the Npas2 shRNA. 
 
Figure 3: 24-Hour expression of Clock in 3111T/C SNP-expressing MEFs. Clock 3111C gene 
expression over 24 hours is significantly higher than Clock 3111T expression. **** = P, 0.0001, *** = P < 0.001,  
** = P < 0.01, * = P < 0.05. 
To test the Clock 3111T/C SNP’s effects on CLOCK protein function, 24-hour Per2 
expression was measured in Clock KO MEFs co-transfected with the 3111T or 3111C constructs 
and the Npas2 shRNA. As a downstream transcriptional target of the CLOCK protein, Per2 is 
rhythmically expressed as part of a transcriptional-translational feedback loop in the molecular 
clock. Therefore, alterations to Per2 expression indirectly reveal differences in CLOCK’s 
transcriptional activity between cells expressing the T or C variant of the SNP. NPAS2 is a 
CLOCK homolog that also serves as a transcriptional activator for Per2, and the Npas2 shRNA 
plasmid was co-transfected along with the human Clock constructs in order to eliminate 
confounds of Per2 expression driven by NPAS2. Using a 2-way ANOVA, we found a significant 
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interaction between SNP and time: SNP x time [F = (21, 95) = 8.52, P <0.0001]. We also found 
that the main effect of the SNP was highly significant; [F = (3, 95) = 523.66, P < 0.0001]. The 
main effect of time was also significant; [F = (7, 95) = 23.67, P < 0.0001]. Bonferroni post-hoc 
testing revealed that in MEFs expressing the Clock 3111C variant and Npas2 shRNA, expression 
of Per2 mRNA is significantly increased at every time point measured. 
 
Figure 4: Fold change 
difference of 24-hour Per2 
expression in 3111T/C-
expressing MEFs. Fold 
change in gene expression 
(for Per2-G418) over 24 
hours reveals a highly 
significant interaction 
between the Clock SNP and 
time of day. **** = P < 
0.0001. 
dCT (Per2-G418) 
**** 
**** 
**** 
**** **** 
**** 
**** 
**** 
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4. DISCUSSION 
Severe circadian rhythm disruptions are prominent symptoms in mood disorders, including BD 
and major depression. There is mounting pre-clinical and clinical data suggesting that circadian 
genes play a role in a number of disease parameters, such as age of onset (Nievergelt et al., 2006; 
Benedetti et al., 2008). Here, we sought to study the implications of the Clock 3111T/C SNP, a 
polymorphism located in the 3’UTR that has been shown to associate with increased frequency 
and severity of manic episodes and actimetric disturbances in BD patients (Benedetti et al., 2003; 
Benedetti et al., 2007; Seretti et al., 2005). Alterations to the 3’UTR have been shown to engage 
in transcriptional and translational regulation through various pathways, including those 
involving mRNA stability and degradation (for review, see Mignone et al., 2002). In addition, 
previous animal research has found that decreased CLOCK activity produces increased 
locomotor and drug- and alcohol-seeking behavior, and decreased depression- and anxiety-like 
behavior – hallmarks of bipolar mania (McClung et al., 2005; Roybal et al., 2007; Ozburn et al., 
2012; Ozburn et al., 2013). Therefore, we sought to test the hypothesis that the 3111C variant of 
the 3111T/C SNP would result in reduced Clock expression and alter Per2 expression (as a 
measure of altered CLOCK transcriptional activity) when compared to the 3111T allele. Using 
cell culture and qPCR, we found that the 3111C variant results in significantly increased Clock 
and Per2 mRNA expression over 24 hours.  
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These findings are very exciting as there is a clear dearth in the literature of molecular 
research of this SNP. The possibility that a clinically-relevant SNP results in increased Clock 
expression is important to many interesting genes, including related circadian genes as well as 
those outside of the molecular clock. For example, in this study, we report that Per2, a gene 
positively regulated by CLOCK, exhibits significantly elevated expression over 24 hours in cells 
expressing the Clock 3111C SNP. This suggests that CLOCK protein levels are also increased.  
In this study, we attempted to control for compensatory overexpression of Npas2 in our 
Clock KO cell culture system using an shRNA to knockdown Npas2 levels. Npas2 knockdown 
reduces possible confounds on our measures of Per2 expression. Interestingly, the dramatic 
change in Per2 expression as a result of Npas2 knockdown in 3111C-expressing cells suggests 
that important interactions between Clock and Npas2 are critical for normal Per2 expression. We 
did not expect to see a significant difference in Per2 expression in 3111T-expressing cells co-
transfected with scramble or Npas2 shRNA. As we predicted, these cells were similar to the WT 
group in Figure 1 in that normal Clock expression was restored, reducing Npas2 upregulation. 
Changes in expression of these related circadian genes may have important implications 
for rhythms of critical physiological processes. Sleep/wake, hormonal, body temperature, and 
blood pressure rhythms, for instance, are all influenced by molecular clockwork. These changes 
may also be important in the understanding and development of effective treatments for mood 
disorders, as current therapies have been shown to strongly phase-shift circadian rhythms. For 
example, selective serotonin reuptake inhibitors (SSRI’s) and morning-light therapy produce 
circadian phase shift advances in the SCN, while lithium and valproate induce phase shift delays 
and period-lengthening (Lewy et al., 2006; Lewy et al., 2007; Terman and Jiuan Su, 2010; 
Dudley et al., 1999; Sprouse et al., 2006).  
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Outside of the molecular clock, changes in Clock expression may have tremendous 
implications for a wide variety of genes that clearly play an important role in regulating mood 
and behavior. Tyrosine hydroxylase (TH), dopamine receptor D3 (DrD3), cholecystokinin 
(CCK), and many other regulators of dopaminergic transmission are under transcriptional control 
by the CLOCK protein (Arey et al., 2013; Ozburn and Falcon et al., submitted; Sidor and 
Spencer et al., submitted). Additionally, mice with an induced mutation of the Clock gene, which 
results in a truncated CLOCK protein with dominant-negative function, express a behavioral 
profile strongly resembling BD patients in the manic state that can be reversed using chronic 
lithium treatment. (Roybal et al., 2007). These mice show increased dopamine synthesis and 
dopamine firing in the ventral tegmental area (VTA), a region featuring important dopaminergic 
projections that have been implicated in psychiatric disorders (Coque et al., 2011). This includes 
an increase in TH expression in the VTA (McClung et al., 2005). Most of the manic-like 
behavioral phenotypes of these mutant mice are rescued with the induced expression of a 
functional CLOCK protein in the VTA, while knockdown of Clock expression in the VTA in 
wild-type mice produces a “mixed state” of reduced anxiety- but increased depression-like 
behavior (Dzirasa et al., 2010; Roybal et al., 2007; Mukherjee et al., 2010). Taking this into 
consideration, it becomes clear to see how a SNP affecting Clock expression can have major 
functional consequences for a number of diseases. 
It is still unclear as to how Clock mRNA levels are increased in cells expressing the 
3111C variant. Changes in mRNA levels for 3111C could be due to increased stability of the 
mRNA. One possible mechanism to explain the increased mRNA stability is that the 3’UTR 
hosts several regulatory elements controlling stability, including binding sites for microRNAs 
(miRNAs). MiRNAs are short, untranslated sequences of RNA that have been shown to have 
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dramatic consequences for mRNA transcript stability (for review, see Keursten and Goodwin, 
2003). For instance, the 3’UTR of the pro-apoptotic gene hid in Drosophila features several 
miRNA binding sites for the bantam miRNA that induce repression of hid mRNA activity 
(Brennecke et al., 2003). The 3’UTR of the Clock gene also features a binding site for miRNA-
182 less than 40 bases from the 3111T/C SNP that may affect stability of the mRNA by 
preventing or activating degradation mechanisms. It is possible that the 3111C variant may 
interfere with this site, reducing miRNA-182 binding and thereby increasing stability and 
elevating levels of Clock mRNA. 
Our studies show that the Clock 3111T/C SNP has important functional consequences by 
increasing Clock and Per2 mRNA expression over 24 hours. We are continuing to investigate 
whether the Clock 3111T/C SNP results in altered CLOCK protein levels, stability, or function 
using native gels for Western Blotting and binding assays. These changes may be due to a 
number of different mechanisms, including miRNA-182 binding sites in the 3’UTR. We plan to 
investigate whether miRNA-182 binding is altered in the 3111T/C SNP using luciferase assays 
and RNA footprinting. Future studies may focus on behavioral studies involving transgenic mice 
that express either version of the 3111T/C SNP. Given that our studies report altered Per2 
expression, the clinical relevance of the SNP may also be further studied by examining whether 
carriers of the 3111C allele respond differently to mood stabilizers that are known to induce 
changes in circadian rhythm phase and period. Although the 3111T/C SNP is only one 
polymorphism of many identified for the Clock gene that associates with BD, these results will 
help to further characterize the functional implications of this clinically-relevant SNP. 
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